Rebion

Private

Boston, MassachusettsHealthcare & Life Scienceshttps://www.rebion.co/

Last Round

Grant

Apr 6, 2022

Total Funding Raised

$3.94M

Company Overview

Rebion is a diagnostic equipment company that has developed a neural performance scanning platform to detect and monitor brain diseases and injuries such as amblyopia (lazy eye) and traumatic brain injury (TBI).

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Computer Vision

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

amblyopia detectionlazy eye screeningpediatric vision screeningvision scannerportable medical devicestrabismus detectionneurotechFDA-cleared medical devicepoint-of-care screeningbrain impairment detectiontraumatic brain injuryTBINeural Performance ScanningNPSAI-augmentedCPT code

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rebion Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Rebion Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Apr 6, 2022
Grant	May 4, 2020
Series A	Oct 1, 2019
Grant	Sep 1, 2016
Grant	Aug 1, 2015

View all Funding Rounds

Rebion Investors

Notable investors and investment history

Investor	Rounds
National Institute of Neurological Disorders and Stroke	Grant
National Eye Institute	Grant
Loudoun County Economic Development Authority	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 6, 2022
$1M grant from the National Institute of Neurological Disorders and Stroke.
May 4, 2020
$25K grant from Loudoun County Economic Development Authority.

View all signals

Rebion Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Rebion Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rebion's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts

Year Founded2009

Last FundingApr 6, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.